
Axon Enterprise, Inc.
- Jurisdiction
United States - LEI
549300QP2IEEGFE16681 - ISIN
US05464C1018 (AXON )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€2.39 24,125.3% overvalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€455.48M - Gross margin
43.0% - EBIT
-€5.49M - EBIT margin
-1.2% - Net income
€756.76K - Net margin
0.2%
Statement period: - (published )
Dividends
No dividend payouts
Products
Product | Revenue | |
---|---|---|
Extended Warranties |
| |
Other |
|
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Mak Jennifer H | Chief Accounting Officer |
|
|
|
|
Isner Joshua | PRESIDENT |
|
|
|
|
Kunins Jeffrey C | CPO & CTO |
|
|
|
|
Partovi Hadi | N/A |
|
|
|
|
SMITH PATRICK W | CHIEF EXECUTIVE OFFICER |
|
|
|
|
Congress transactions
Name | Transaction date | Value |
---|---|---|
Jefferson Shreve | June 22, 2025 | $15.00K–$50.00K |
Jefferson Shreve | April 11, 2025 | $15.00K–$50.00K |
Robert Bresnahan | February 13, 2025 | $1.00K–$15.00K |
Markwayne Mullin | December 18, 2024 | $15.00K–$50.00K |
Earnings Calls
Latest earnings call: February 27, 2024
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Nancy Zevenbergen |
|
|
|
Sell |
James Anderson |
|
|
|
Sell |